Isatin analog as bruton tyrosine kinase inhibitor: A promising novel agent for multiple myeloma treatment

被引：1
|
作者：
Gowda, Krishne [1 ]
Pandey, Manoj K. [1 ]
Sharma, Arun K. [1 ]
Amin, Shantu [1 ]
机构：
[1] Penn State Univ, Coll Med, Hershey, PA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4204
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Bruton's tyrosine kinase: potential target in human multiple myeloma
    Liu, Ying
    Dong, Ying
    Jiang, Qian-Li
    Zhang, Bo
    Hu, An-Mei
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 177 - 181
  • [12] The first oral Bruton Tyrosine Kinase Inhibitor for the Treatment of CLL
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 707 - 707
  • [13] Bruton's tyrosine kinase: oncotarget in myeloma
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    ONCOTARGET, 2012, 3 (09) : 913 - 914
  • [14] Bruton's tyrosine kinase inhibitors in the treatment of multiple sclerosis
    Shulga, Olga
    Chabanova, Anna
    Kotsiuba, Oleksandra
    POSTEPY PSYCHIATRII I NEUROLOGII, 2023, 32 (01): : 23 - 30
  • [15] The Promising Impact of Ibrutinib, a Bruton's Tyrosine Kinase Inhibitor, for the Management of Lymphoid Malignancies
    Bhatt, Valkal
    Alejandro, Linh
    Michael, Angela
    Ganetsky, Alex
    PHARMACOTHERAPY, 2014, 34 (03): : 303 - 314
  • [16] PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies
    Winer, Eric S.
    Ingham, Randall R.
    Castillo, Jorge J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (03) : 355 - 361
  • [17] A Novel Bruton's Tyrosine Kinase Inhibitor CC-292 In Combination With The Proteasome Inhibitor Carfilzomib Iimpacts Multiple Myeloma Bone Microenviroment With Resultant Anti-Myeloma Activity
    Eda, Homare
    Santo, Loredana
    Cirstea, Diana D.
    Yee, Andrew J.
    Scullen, Tyler A.
    Nemani, Neeharika
    Mishima, Yuko
    Arastu-Kapur, Shirin
    Evans, Erica
    Singh, Juswinder
    Kirk, Christopher J.
    Westlin, William F.
    Raje, Noopur S.
    BLOOD, 2013, 122 (21)
  • [18] Effectiveness of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in a Novel Model for Compartmentalized Neuroinflammation in Multiple Sclerosis
    Kebir, H.
    Li, C.
    May, M. J.
    Church, M. E.
    Boschert, U.
    Alvarez, J. I.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 8 - 9
  • [19] OTX015, a novel BET inhibitor, is a promising anticancer agent for multiple myeloma
    Todaro, Maria
    Boi, Michela
    Vurchio, Valentina
    Ercole, Elisabetta
    Machiorlatti, Rodolfo
    Messana, Katia
    Landra, Indira
    Urigu, Susanna
    Aliberti, Sabrina
    Riveiro, Eugenia
    Bertoni, Francesco
    Inghirami, Giorgio
    CANCER RESEARCH, 2014, 74 (19)
  • [20] Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia
    Wolska-Washer, Anna
    Robak, Tadeusz
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 183 - 194
12345